Xiaoxing Wu

机构：China Pharmaceutical University, Medicina · ORCID：0000-0003-3378-1299

发表论文 115 篇 · 总被引 3313 次 · h-index 30

代表论文

• A Dual‐Responsive Morphologically‐Adaptable Nanoplatform for Targeted Delivery of Activatable Photosensitizers in Precision Photodynamic Therapy (2023 · Small · 被引 33)
• Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia (2024 · Journal of Medicinal Chemistry · 被引 26)
• Development of Son of Sevenless Homologue 1 (SOS1) Modulators To Treat Cancers by Regulating RAS Signaling (2023 · Journal of Medicinal Chemistry · 被引 23)
• Design and Synthesis of Sulfonium Derivatives: A Novel Class of α-Glucosidase Inhibitors with Potent In Vivo Antihyperglycemic Activities (2023 · Journal of Medicinal Chemistry · 被引 21)
• Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based SHP2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of KRAS Mutant Cancers (2023 · Journal of Medicinal Chemistry · 被引 13)
• Cascade-Activated AIEgen-Peptide Probe for Noninvasively Monitoring Chymotrypsin-like Activity of Proteasomes in Cancer Cells (2023 · Analytical Chemistry · 被引 13)